An international comparison of male and female breast cancer incidence rates

International Journal of Cancer

Volumn 132, Issue 8, 2013, Pages 1918-1926

  Ly, Diana ^a   Forman, David ^b   Ferlay, Jacques ^b   Brinton, Louise A ^a   Cook, Michael B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

breast neoplasms; epidemiology; female; incidence; male; sex; trends

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; ISRAEL; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SEX RATIO; THAILAND; TREND STUDY; UNITED STATES;

BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; INCIDENCE; INTERNATIONALITY; MALE;

EID: 84873997754     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27841     Document Type: Article

References (50)

1. Cook MB, Dawsey SM, Freedman ND, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 2009; 18: 1174-82.
2. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2012.
3. Miao H, Verkooijen HM, Chia KS, et al. Incidence and outcome of male breast cancer: an international population-based study. J Clin Oncol 2011; 29: 4381-6.
4. Anderson WF, Jatoi I, Tse J, et al. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 2010; 28: 232-9.
5. Greif JM, Pezzi CM, Klimberg VS, et al. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base. Ann Surg Oncol 2012; 19: 3199-204.
6. Gnerlich JL, Deshpande AD, Jeffe DB, et al. Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Ann Surg Oncol 2011; 18: 1837-44.
7. Shaaban AM, Ball GR, Brannan RA, et al. A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat 2012; 133: 949-58.
8. Thalib L, Hall P,. Survival of male breast cancer patients: population-based cohort study. Cancer Sci 2009; 100: 292-5.
9. Goodman MT, Tung KH, Wilkens LR,. Comparative epidemiology of breast cancer among men and women in the US, 1996 to 2000. Cancer Causes Control 2006; 17: 127-36.
10. Burga AM, Fadare O, Lininger RA, et al. Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases. Virchows Arch 2006; 449: 507-12.
11. Johansson I, Nilsson C, Berglund P, et al. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker. Breast Cancer Res 2012; 14: R31.
12. Callari M, Cappelletti V, De Cecco L, et al. Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer. Breast Cancer Res Treat 2011; 127: 601-10.
13. Johansson I, Nilsson C, Berglund P, et al. High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer. Breast Cancer Res Treat 2011; 129: 747-60.
14. Brinton LA, Carreon JD, Gierach GL, et al. Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat 2010; 119: 185-92.
15. Brinton LA, Richesson DA, Gierach GL, et al. Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst 2008; 100: 1477-81.
16. Lynge E, Afonso N, Kaerlev L, et al. European multi-centre case-control study on risk factors for rare cancers of unknown aetiology. Eur J Cancer 2005; 41: 601-12.
17. Johnson KC, Pan S, Mao Y,. Risk factors for male breast cancer in Canada, 1994-1998. Eur J Cancer Prev 2002; 11: 253-63.
18. Parkin DM, Ferlay J, Curado MP, et al. Fifty years of cancer incidence: CI5 I-IX. Int J Cancer 2010; 127: 2918-27.
19. Segi M,. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Public Health, 1960.
20. Doll R, Payne P, Waterhouse J,. Cancer incidence in five continents: a technical reported. Berlin: Springer-Verlag (for UICC), 1966.
21. Tiwari RC, Clegg LX, Zou Z,. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res 2006; 15: 547-69.
22. National Cancer Institute. Introduction to SEER and Stat. Bethesda, MD, 2008. http://smm.sagepub.com/.
23. The World Bank. Health expenditure per capita (current US$): the World Bank. http://data.worldbank.org/indicator/SH.XPD.PCAP?page=2 (accessed on May 25, 2012).
24. National Cancer Institute. International cancer screening network, vol. 2012. http://appliedresearch.cancer.gov/icsn/breast/screening.html (accessed on May 25, 2012).
25. von Karsa, L, Anttila, A, Ronco, G, et al. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. First Report. IARC/European Commission http://ec.europa.eu/ health/ph-determinants/genetics/documents/cancer-screening.pdf, 2008.
26. IARC. Cancer incidence in five continents, vol. 9. Lyon, IARC: IARC Scientific Publications no. 160, 2007.
27. IARC. Cancer incidence in five continents. IARC Sci Publ 2002; 8: 1-781.
28. IARC. Cancer incidence in five continents, vol. 7. Lyon: International Agency for Research on Cancer, 1997.
29. Roa BB, Boyd AA, Volcik K, et al. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 1996; 14: 185-7.
30. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-8.
31. Im KM, Kirchhoff T, Wang X, et al. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet 2011; 130: 685-99.
32. Tai YC, Domchek S, Parmigiani G, et al. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2007; 99: 1811-4.
33. Ewertz M, Holmberg L, Tretli S, et al. Risk factors for male breast cancer-a case-control study from Scandinavia. Acta Oncol 2001; 40: 467-71.
34. Hsing AW, McLaughlin JK, Cocco P, et al. Risk factors for male breast cancer (United States). Cancer Causes Control 1998; 9: 269-75.
35. Anderson WF, Althuis MD, Brinton LA, et al. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 2004; 83: 77-86.
36. Shaaban AM, Ball GR, Brannan RA, et al. A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat 2012; 133: 949-58.
37. Glass AG, Lacey JV, Jr, Carreon JD, et al. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 2007; 99: 1152-61.
38. Jonsson H, Johansson R, Lenner P,. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 2005; 117: 842-7.
39. Verkooijen HM, Bouchardy C, Vinh-Hung V, et al. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence. Maturitas 2009; 64: 80-5.
40. Welch HG, Black WC,. Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102: 605-13.
41. Iwasaki M, Tsugane S,. Risk factors for breast cancer: epidemiological evidence from Japanese studies. Cancer Sci 2011; 102: 1607-14.
42. Hill TD, Khamis HJ, Tyczynski JE, et al. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Ann Epidemiol 2005; 15: 773-80.
43. Stang A, Thomssen C,. Decline in breast cancer incidence in the United States: what about male breast cancer? Breast Cancer Res Treat 2008; 112: 595-6.
44. Speirs V, Shaaban AM,. The rising incidence of male breast cancer. Breast Cancer Res Treat 2009; 115: 429-30.
45. Shin HR, Joubert C, Boniol M, et al. Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women. Cancer Causes Control 2010; 21: 1777-85.
46. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85: 1819-27.
47. McPherson K, Steel CM, Dixon JM,. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 2000; 321: 624-8.
48. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007; 356: 1670-4.
49. Nicholson WJ, Davis DL,. Analyses of changes in the ratios of male-to-female cancer mortality. A hypothesis-generating exercise. Ann NY Acad Sci 1990; 609: 290-7; discussion 7-9.
50. Wingard DL,. The sex differential in morbidity, mortality, and lifestyle. Annu Rev Public Health 1984; 5: 433-58.